文献速递脊柱关节炎其他结缔组织病

多参数磁共振成像评估银屑病和银屑病关节炎中MASLD患病率高

High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

COLIPSO多中心前瞻性研究纳入50例接受标准系统治疗的银屑病疾病成人,用多参数MRI评估肝脂肪与纤维炎症,并与360例银屑病疾病患者、150例匹配对照及150例健康对照比较。银屑病疾病组脂肪性肝病患病率44%,高于匹配对照的25%(P=0.02);MASH患病率22%,高于匹配对照的3%(P<0.001);24例合并肝病的银屑病疾病患者中13例肝功能血检正常。

要点

  • 银屑病疾病组脂肪性肝病患病率44%,高于匹配对照的25%(P=0.02)。
  • 银屑病疾病组MASH患病率22%,高于匹配对照的3%(P<0.001)。
  • 24例合并肝病的银屑病疾病患者中13例(54%)肝功能血检正常;有无甲氨蝶呤暴露者肝病程度无显著差异。

核心结论

  • 银屑病疾病患者MASLD和MASH患病率更高,且可被血液检查漏诊,在无甲氨蝶呤暴露者中亦存在;作者认为应使用多参数MRI等更敏感工具对该人群进行常规MASLD筛查。

研究设计与样本

  • COLIPSO为多中心前瞻性研究,纳入在二级医疗接受标准系统治疗的银屑病疾病成人。
  • 50例参与者接受临床评估及肝脏健康无创检测,包括肝脏纤维炎症和脂肪含量的MRI生物标志物。
  • 结果与360例银屑病疾病患者、150例按年龄、性别、BMI和合并症匹配的无银屑病疾病对照及150例来自UK Biobank和COVERSCAN研究的健康对照比较。
  • 采用Spearman秩相关和多变量线性回归模型分析关联。

主要发现

  • 银屑病疾病组(年龄48岁,58%男性,BMI 29 kg/m2)脂肪性肝病患病率为44%,高于匹配对照的25%(P=0.02)。
  • 银屑病疾病组MASH患病率为22%,匹配对照为3%(P<0.001)。
  • 24例合并肝病的银屑病疾病患者中13例(54%)肝功能血液检查正常。
  • 有无既往甲氨蝶呤暴露者之间肝病水平无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Psoriatic disease (PsD) is a chronic inflammatory condition associated with obesity, metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH). We aimed to determine the prevalence of MASLD/MASH in a real-world psoriatic cohort using advanced imaging. METHODS: COLIPSO is a multicentre, prospective study of adults with PsD receiving standard systemic therapy in secondary care. Fifty participants underwent clinical assessments and non-invasive tests of liver health, including MRI-biomarkers of liver fibro-inflammation and fat content. These were compared with 360 individuals with PsD, with 150 controls without PsD (matched for age, sex, BMI and comorbidities) and 150 healthy controls from the UK Biobank and COVERSCAN studies. Associations were investigated with Spearman's rank correlations and multivariate linear regression models. RESULTS: The prevalence of steatotic liver disease was 44% in the PsD group (aged 48 years, 58% male, BMI 29 kg/m2) and higher than in matched controls (25%, P = 0.02). MASH was prevalent in 22% of PsD patients (vs 3% in matched controls, P < 0.001). Thirteen of the 24 (54%) individuals with PsD and liver disease had normal liver function blood tests. No significant difference in levels of liver disease was observed between those with or without prior exposure to methotrexate. CONCLUSIONS: Individuals with PsD exhibit higher prevalence of MASLD and MASH that was missed by blood tests and was present even in individuals with no methotrexate exposure. These findings underscore the importance of routine MASLD screening in this population with more sensitive tools, such as multi parametric MRI.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. James L, Diamond C, Al-Mossawi H, et al. High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging. Rheumatology (Oxford). 2025. PMID: 40569171. doi:10.1093/rheumatology/keaf344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。